Ultrasound Visceral Slide Test for Prediction of Periumblical Adhesions Before Gynecologic Laparoscopic Surgery

Sponsor
Barzilai Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT03631888
Collaborator
(none)
80
1
17.5
4.6

Study Details

Study Description

Brief Summary

Ultrasound visceral slide test for prediction of periumbilical adhesions before gynecologic laparoscopic surgery: a prospective cohort study.

The investigators are planning to conduct a prospective study to evaluate if there is an effect of abdominal wall thickness and body mass index on slide distance of visceral organ during ultrasound examination.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: preoperative abdominal ultrasound examination

Study Design

Study Type:
Observational
Actual Enrollment :
80 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Ultrasound Visceral Slide Test for Prediction of Periumblical Adhesions Before Gynecologic Laparoscopic Surgery: a Prospective Cohort Study
Actual Study Start Date :
Feb 11, 2019
Actual Primary Completion Date :
Jul 12, 2020
Actual Study Completion Date :
Jul 27, 2020

Arms and Interventions

Arm Intervention/Treatment
patients scheduled for elective laparoscopic surgery

Diagnostic Test: preoperative abdominal ultrasound examination
Performing preoperative abdominal ultrasound examination in patients that will be scheduled for elective laparoscopic surgery for any gynecologic indication

Outcome Measures

Primary Outcome Measures

  1. Visceral Slide Test [2 minutes]

    correlation between abdominal wall thickness(mm) and sliding distance of visceral organ(mm) during ultrasound examination

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients scheduled for elective laparoscopic surgery for any gynecologic indication.
Exclusion Criteria:
  • Emergency laparoscopic surgery

  • Patients under age 18

Contacts and Locations

Locations

Site City State Country Postal Code
1 Barzilai University Medical Center Ashkelon Israel

Sponsors and Collaborators

  • Barzilai Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ahmad Namazov, Principal investigator, Barzilai Medical Center
ClinicalTrials.gov Identifier:
NCT03631888
Other Study ID Numbers:
  • BRZ 0024-18 CTIL
First Posted:
Aug 15, 2018
Last Update Posted:
Jul 29, 2020
Last Verified:
Jul 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 29, 2020